EOLS EVOLUS INC
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about EVOLUS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on EOLS from 4 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: BTIG Research raised its target from $13.00 (set 17 Jun 2026) to $15.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Sam Eiber | Buy | 17 Jun 2026 | 13.00 USD |
| H.C. Wainwright | Douglas Tsao | Buy | 25 Aug 2026 | 13.00 USD |
| Leerink Partners | Marc Goodman | Buy | 17 Sep 2026 | 20.00 USD |
| Mizuho | Uy Ear | — | 4 Feb 2026 | 15.00 USD |
| Needham | Serge Belanger | Hold | 1 Jul 2026 | — |
| Stifel | Annabel Samimy | Buy | 13 Jan 2026 | 17.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.